De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study

V. Guarneri, M.V. Dieci, G. Bisagni, A. Frassoldati, G.V. Bianchi, G.L. De Salvo, E. Orvieto, L. Urso, T. Pascual, L. Paré, P. Galván, M. Ambroggi, C.A. Giorgi, G. Moretti, G. Griguolo, R. Vicini, A. Prat, P.F. Conte

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)921-926
Number of pages6
JournalAnnals of Oncology
Issue number6
Publication statusPublished - 2019

Cite this